Peptide Therapeutics intermediate
Linaclotide - IBS-C (NCT00765882)
Phase III trial of linaclotide for IBS-C. This peptide or oligopeptide is studied for its biological activity, structure-activity relationships, and potentia...
By Encyclopeptide Editorial | 1 min read
linaclotide-ibs-c-nct00765882 peptide research
Overview
Phase III trial of linaclotide for IBS-C.
Clinical Significance
This topic has important implications for peptide research and clinical applications.
References
- Encyclopeptide Database. “Linaclotide - IBS-C (NCT00765882)” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Linaclotide - IBS-C (NCT00765882) with interactive quizzes on Wikipept.
Take a Quiz on Wikipept